---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-045249"
form_type: "8-K/A"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2023-09-26T23:59:59+00:00"
generated_at: "2026-06-10T09:02:48.310082+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Dorothy J. Clarke appointed to all three committees of Eterna Therapeutics Board

## Summary
- Dorothy J. Clarke appointed to Audit Committee, Compensation Committee, and Nominating and Governance Committee.
- Appointment effective September 23, 2023; committee roles are immediate.
- Clarke joined the Board on August 28, 2023, for term through 2024 annual meeting.

## SEC filing metadata
- accession: 0001140361-23-045249
- form_type: 8-K/A
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2023-09-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000114036123045249/0001140361-23-045249-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000114036123045249/ef20011289_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-045249
- JSON: https://secwatch.observer/filing/0001140361-23-045249.json
- Plain text: https://secwatch.observer/filing/0001140361-23-045249.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.